New cream promises firmer, hydrated skin for aging adults

NCT ID NCT07398989

First seen Feb 14, 2026 · Last updated Jun 23, 2026 · Updated 13 times

Summary

This study tested a topical skincare product, Cetaphil Hydrating and Firming Cream, on 32 adults aged 40-60 with mild-to-moderate crepey skin. Participants applied the cream twice daily to knees, thighs, and hands for 12 weeks. Researchers measured changes in skin hydration, firmness, and texture using clinical grading and devices like a Corneometer. The goal was to see if the cream could improve skin condition without irritation.

Disclaimer Read more

This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for PHOTO-AGED SKIN are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Contacts and locations

Locations

  • Ablon Skin Institute & Research Center

    Manhattan Beach, California, 90266, United States

  • Clinical Research Center of the Carolinas

    Charleston, South Carolina, 29407, United States

What this could mean

Our plain-language read of the trial. This is informational only — not medical advice or a prediction.

Active substance

Cetaphil Hydrating and Firming Cream Skin Activator

What this could lead to

If it works, this could provide a simple, over-the-counter option to improve skin hydration and firmness in aging skin.

What could go wrong

This is a small, completed Phase 4 trial with only 32 participants, so results may not apply to everyone. The product is a cosmetic cream, not a medical treatment for serious skin conditions.

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.